Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications.

about

Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications.

Item

http://www.wikidata.org/entity/Q52312048

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Analysis of Clinical Drug-Drug ...... viral Drugs and Comedications.

@en

Analysis of Clinical Drug-Drug ...... viral Drugs and Comedications.

@nl

type

Item

label

Analysis of Clinical Drug-Drug ...... viral Drugs and Comedications.

@en

Analysis of Clinical Drug-Drug ...... viral Drugs and Comedications.

@nl

prefLabel

Analysis of Clinical Drug-Drug ...... viral Drugs and Comedications.

@en

Analysis of Clinical Drug-Drug ...... viral Drugs and Comedications.

@nl

P1476

Analysis of Clinical Drug-Drug ...... viral Drugs and Comedications.

@en

P2093

Andrew Owen

http://www.w3.org/2001/XMLSchema#string

Catia Marzolini

http://www.w3.org/2001/XMLSchema#string

Felix Stader

http://www.w3.org/2001/XMLSchema#string

Hannah Kinvig

http://www.w3.org/2001/XMLSchema#string

Marco Siccardi

http://www.w3.org/2001/XMLSchema#string

Saye Khoo

http://www.w3.org/2001/XMLSchema#string

P2860

Recent Advances in Development and Application of Physiologically-Based Pharmacokinetic (PBPK) Models: a Transition from Academic Curiosity to Regulatory Acceptance

Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.

Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection

Cytochrome P450 3A: ontogeny and drug disposition.

Application of a Physiologically Based Pharmacokinetic Model to Predict OATP1B1-Related Variability in Pharmacodynamics of Rosuvastatin.

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole.

Dose of midazolam should be reduced during diltiazem and verapamil treatments.

Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers

Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.

P31

scholarly article

P356

10.1128/AAC.00717-18

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manuel Battegay

P577

2018-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29686151

http://www.w3.org/2001/XMLSchema#string

P932

6021627

http://www.w3.org/2001/XMLSchema#string